Momenta Pharmaceuticals, Inc. (MNTA)

[alternatepatel]

Reg. Dr. Reddy's

From their latest conference call (occurred on October 31, 2017) :

It’s 10th November for 20 mg, and sometime in March for the 40 mg. I think the last we’ve heard that post-Mylan’s approval, our file is in active review. Beyond that, we can’t comment and so we hope to hear something next month in terms of, certainly there would be follow-up questions and some of those questions will be mostly on the DMF side, which will be applicable for the 40 mg as well, and hence to that extent some of the work would be done ahead of the 40 mg.

I would not expect them to get approval till March 18 at least, however they can still beat $MNTA on 40 mg.